OOIR: Observatory of International Research

Papers

(The TQCC of Drug Metabolism Reviews is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
The annoying flaws of gerontological research	42
Drug transporters in drug disposition – the year 2022 in review	33
Cell-Biomaterial constructs for wound healing and skin regeneration	29
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids	28
Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models	25
Bioanalytical strategies in drug discovery and development	19
New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments	19
An in-depth review of PPARγ modulators as anti-diabetes therapeutics	18
Mechanisms of intestinal pharmacokinetic natural product-drug interactions	17
Cytochrome P450-mediated carbon-carbon bond formation in drug metabolism	15
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations	14
Rodent genetic models of Ah receptor signaling	13
Biopolymers as promising vehicles for drug delivery to the brain	13
Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special population	12
Genetic determinants of paclitaxel-induced peripheral neuropathy: a review of current literature	12
Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice	12
Scaling factors to inform in vitro - in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations	11
Clinical pharmacokinetics of nebivolol: a systematic review	11
Recent advances in drug transporter sciences: highlights from the year 2020	10
In silico ADME and target prediction studies of Alogliptin as drug molecule	10
A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism	10
Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods	10